Home
Our Solution
Pipeline
For Patients
News
About Us
News
All of our latest updates
Press releases
News
March 26, 2024
Results from first pancreatic cancer trial using immunostimulatory gene therapy is published in Lancet Oncology
January 12, 2022
Lokon Pharma Initiates a Collaboration with Affibody to Develop Novel Cancer Therapeutics
August 28, 2020
Lokon Pharma Expands Collaboration with Roche Evaluating LOAd703 Immunostimulatory Gene Cancer Therapy in Combination with Tecentriq® (atezolizumab) into Colorectal Cancer
June 3, 2019
Lokon Pharma Announces Collaboration to Combine LOAd703 Oncolytic Virotherapy with Checkpoint Blockade in Pancreatic Cancer and Melanoma
January 19, 2017
First Patient Treated by a Novel Oncolytic Virus Armed with Immune Stimulators
September 28, 2022
Preliminary data from LOKON002, LOAd703 treatment of solid malignancies will be presented by Dr Emma Eriksson, Head of R&D at CICON.
June 5, 2022
Dr Benjamin Musher (Baylor College of Medicine) presented data from LOKON001 arm 1 study on pancreatic cancer at ASCO.
April 8, 2022
Lokon’s triple armed virus LOAd732 will be presented by Jessica Wenthe (Uppsala University) at AACR this year!
Previous
See more
Media
Malou efter 10
Bengt fick aggressiv cancer - hade ett år kvar att leva
Barncancerfonden
Immunterapi på 100 sekunder
Malou efter 10
Forskarna om cancervaccinet: ”Behövs pengar”
Uppsala universitet
Immunterapi är ett nytt sätt att bekämpa cancer.
